News
Center
Homepage
/
News Center
/
Interview of Zaiqi Wang – Chairman & CEO, InxMed by PharmaBoardroom
Interview of Zaiqi Wang – Chairman & CEO, InxMed by PharmaBoardroom
2020-08-26 15:04
Previous
InxMed Announced the Completion of RMB 130M (~US$ 19M) Series A+ Financing to Accelerate Its Clinical Development and Strengthen Translational Capabilities
Next
InxMed Released Research Data of “FAK inhibitor IN10018 overcomes drug resistance of KRAS G12C inhibition” at 2020 AACR Annual Meeting
Previous
:
InxMed Announced the Completion of RMB 130M (~US$ 19M) Series A+ Financing to Accelerate Its Clinical Development and Strengthen Translational Capabilities
Next
:
InxMed Released Research Data of “FAK inhibitor IN10018 overcomes drug resistance of KRAS G12C inhibition” at 2020 AACR Annual Meeting
Copyright © 2019 InxMed
京ICP备19001572号-1
Powered by 300.cn
EN
|
中文
